LONA
LeonaBio, Inc. · Healthcare
Insiders sold $56K net in the last 90 days ·5 sellers, 0 buyers· latest Form 4 filed Mar 5, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$56K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Mar 5, 2026
Renninger Robert
LeonaBio, Inc. (LONA) has 5 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Mar 5, 2026.
Inside the rolling window, 5 insiders at LeonaBio, Inc. reported no open-market purchases and 5 open-market sales totaling $56K. The most recent open-market filing is a sale of 906 shares by CHIEF FINANCIAL OFFICER Renninger Robert, dated Mar 4, 2026, worth $5K.
- Industry:Biotechnology
- CEO:Mark J. Litton
- Employees:19
- HQ:Bothell, WA, US
- IPO:2020-09-18
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does LONA have?
LeonaBio, Inc. (LONA) has 5 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Mar 5, 2026.
When was the most recent SEC Form 4 filing for LONA?
The most recent Form 4 filing for LONA on Tracefour is dated Mar 5, 2026.
What is the net insider flow at LONA over the last 6 months?
Over the trailing 180 days, insiders at LONA have net sold $56K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at LONA in the current window?
Inside the rolling window, insiders at LONA bought $0 and sold $56K based on SEC Form 4 filings.
Can I get alerts for LONA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at LeonaBio, Inc. (LONA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
LeonaBio, Inc. is in the Healthcare sector.